Skip to main content
| Hans-Günter Meyer-Thompson | Opioide

USA. Challenges in Identifying Novel Psychoactive Substances and a Stronger Path Forward

USA. Challenges in Identifying Novel Psychoactive Substances and a Stronger Path Forward

The importance of non-targeted testing to keep pace with a rapidly evolving synthetic opioid market. (NIJ – National Institute of Justice, USA, 11.06.2022)

https://nij.ojp.gov/topics/articles/challenges-identifying-novel-psychoactive-substances-and-stronger-path-forward